The prospective study of antithrombotic therapies in cardiovascular diseases to elucidate the clinical problems and to develop management strategies.
Not Applicable
- Conditions
- Cardiovascular diseases
- Registration Number
- JPRN-UMIN000022471
- Lead Sponsor
- Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine / Tohoku Heart Failure Association
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 7274
Inclusion Criteria
Not provided
Exclusion Criteria
Not applicable
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie antithrombotic therapy efficacy in JPRN-UMIN000022471 cardiovascular disease patients?
How does JPRN-UMIN000022471 compare direct oral anticoagulants to vitamin K antagonists in atrial fibrillation management?
Which biomarkers correlate with antithrombotic response in JPRN-UMIN000022471 coronary artery disease subpopulations?
What adverse event profiles are reported for antithrombotic regimens in JPRN-UMIN000022471 observational study?
How do JPRN-UMIN000022471 findings inform combination therapies with antiplatelet agents and IL-6 inhibitors for heart failure?